According to Fulgent Genetics
's latest financial reports the company has a price-to-book ratio of 0.5298.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.7559 | 6.65% |
2022-12-31 | 0.7088 | -72.46% |
2021-12-31 | 2.57 | -0.18% |
2020-12-31 | 2.58 | -22.99% |
2019-12-31 | 3.35 | 197.29% |
2018-12-31 | 1.13 | -21.84% |
2017-12-31 | 1.44 | -61.62% |
2016-12-31 | 3.75 | |
2015-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | -1.01 | -289.78% | ๐บ๐ธ USA |
Philips PHG | 1.45 | 174.17% | ๐ณ๐ฑ Netherlands |